<DOC>
	<DOC>NCT02645682</DOC>
	<brief_summary>The purpose of this study is to investigate the effect of anti-infective central venous catheter(Certofix®Protect) on reducing catheter-related bloodstream infection in critically ill patients in China, and the relationship between catheter-related bloodstream infection and catheter-related thrombosis.</brief_summary>
	<brief_title>The Effects of Anti-infective Central Venous Catheter on Catheter-related Infection in Critically Patients</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Catheter-Related Infections</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>adult patients in intensive care unit (ICU)（age ≥ 18 years） needs double lumen CVC more than 5 days Signed informed consent thrombosis in target and/or contralateral vein pregnancy or lactating women unlikely to survive for more than 1 month bad prognosis suspected catheterrelated infection replacement CVC in original site through guide wire severe burn situation that is not suitable for CVC, including allergic to CVC material, thrombosis in target vein, infection of puncture site, coagulation disorder, abnormal anatomy already in this study participated in other studies within 3 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>central venous catheter (CVC)</keyword>
	<keyword>catheter-related bloodstream infection (CRBSI)</keyword>
	<keyword>catheter-related thrombosis (CRT)</keyword>
</DOC>